85 results on '"Hoffman TM"'
Search Results
2. Report of the pediatric heart network and national heart, lung, and blood institute working group on the perioperative management of congenital heart disease.
- Author
-
Kaltman JR, Andropoulos DB, Checchia PA, Gaynor JW, Hoffman TM, Laussen PC, Ohye RG, Pearson GD, Pigula F, Tweddell J, Wernovsky G, Del Nido P, Perioperative Working Group, Kaltman, Jonathan R, Andropoulos, Dean B, Checchia, Paul A, Gaynor, J William, Hoffman, Timothy M, Laussen, Peter C, and Ohye, Richard G
- Published
- 2010
- Full Text
- View/download PDF
3. Increased calcium supplementation is associated with morbidity and mortality in the infant postoperative cardiac patient.
- Author
-
Dyke PC II, Yates AR, Cua CL, Hoffman TM, Hayes J, Feltes TF, Springer MA, and Taeed R
- Published
- 2007
- Full Text
- View/download PDF
4. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient.
- Author
-
Yates AR, Dyke PC, Taeed R, Hoffman TM, Hayes J, Feltes TF, and Cua CL
- Published
- 2006
- Full Text
- View/download PDF
5. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease.
- Author
-
Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL, Hoffman, Timothy M, Wernovsky, Gil, Atz, Andrew M, Kulik, Thomas J, Nelson, David P, Chang, Anthony C, Bailey, James M, and Akbary, Akbar
- Published
- 2003
6. Heart transplantation for pediatric patients with malignant arrhythmias: Indications and Outcomes.
- Author
-
Atallah J, Urschel S, Kirklin JK, Cantor R, Zhao H, Motiuk J, Hoffman TM, Weisert M, Lytrivi ID, Singh NM, Azeka E, and Wittlieb-Weber CA
- Abstract
Background: Arrhythmias can lead to cardiac arrest and heart failure. When intractable, heart transplantation (HTX) can become the only viable treatment. This rare high-risk cohort has not been reported as a distinct group., Objective: The purpose of this study was to characterize the outcomes of pediatric patients listed for HTX with the primary indication being malignant arrhythmia (MA)., Methods: Using the Pediatric Heart Transplant Society prospective registry, we identified all patients younger than 18 years listed between 2014 and 2022. MA as the listing indication was categorized into primary tachyarrhythmia (PT), inherited arrhythmia (IA), congenital heart disease, and cardiomyopathy (CM) with secondary arrhythmia. Demographic, listing, and transplant data were analyzed., Results: Among 4630 patients listed and 3317 transplanted, MA was the indication in 63 (1.4%) and 49 (1.5%), respectively. Patients with MA were categorized as PT in 11 (17%), IA in 4 (6%), congenital heart disease in 6 (10%), and CM in 42 (67%). Compared with the non-MA cohort, patients listed for MA were older (mean age 10.6 ± 6.2 years vs 6.1 ± 6.2 years; P < .01), more likely to present with cardiac arrest (43% vs 11%; P < .01), and less likely to be in the intensive care unit (40% vs 58%; P < .01) or on inotropes (30% vs 60%; P < .01) at the time of listing. Outcomes including waitlist mortality, transplantation, posttransplant survival, and freedom from rejection were comparable to those of the non-MA cohort., Conclusion: Patients with MA constitute a small proportion of those listed for HTX in childhood. CM was the most common category, while IA and PT were rare. Their waitlist mortality and posttransplant outcomes were comparable to those of the non-MA cohort., Competing Interests: Disclosures Dr Wittlieb-Weber is a consultant for Pfizer (no conflict related to this study). Dr Kirklin is President of Kirklin Solutions, Inc. (no conflict related to this study). The remaining authors have no conflicts to disclose., (Copyright © 2024 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Novel linkage of the Society of Thoracic Surgeons database and hospital electronic health records.
- Author
-
Atkins CA, Nellis JR, Vekstein AM, D'Ottavio A, DeLaRosa JM, Chiswell K, Turek JW, Beckerman Z, Raskind Hood C, Book WM, Hoffman TM, Hartman RJ, Walsh M, Li JS, and Welke KF
- Abstract
Background: Society of Thoracic Surgeons Congenital Heart Surgery Database is the largest congenital heart surgery database worldwide but does not provide information beyond primary episode of care. Linkage to hospital electronic health records would capture complications and comorbidities along with long-term outcomes for patients with CHD surgeries. The current study explores linkage success between Society of Thoracic Surgeons Congenital Heart Surgery Database and electronic health record data in North Carolina and Georgia., Methods: The Society of Thoracic Surgeons Congenital Heart Surgery Database was linked to hospital electronic health records from four North Carolina congenital heart surgery using indirect identifiers like date of birth, sex, admission, and discharge dates, from 2008 to 2013. Indirect linkage was performed at the admissions level and compared to two other linkages using a "direct identifier," medical record number: (1) linkage between Society of Thoracic Surgeons Congenital Heart Surgery Database and electronic health records from a subset of patients from one North Carolina institution and (2) linkage between Society of Thoracic Surgeons data from two Georgia facilities and Georgia's CHD repository, which also uses direct identifiers for linkage., Results: Indirect identifiers successfully linked 79% (3692/4685) of Society of Thoracic Surgeons Congenital Heart Surgery Database admissions across four North Carolina hospitals. Direct linkage techniques successfully matched Society of Thoracic Surgeons Congenital Heart Surgery Database to 90.2% of electronic health records from the North Carolina subsample. Linkage between Society of Thoracic Surgeons and Georgia's CHD repository was 99.5% (7,544/7,585)., Conclusions: Linkage methodology was successfully demonstrated between surgical data and hospital-based electronic health records in North Carolina and Georgia, uniting granular procedural details with clinical, developmental, and economic data. Indirect identifiers linked most patients, consistent with similar linkages in adult populations. Future directions include applying these linkage techniques with other data sources and exploring long-term outcomes in linked populations.
- Published
- 2024
- Full Text
- View/download PDF
8. Risk Factors and Outcomes Associated with Gaps in Care in Children with Congenital Heart Disease.
- Author
-
Rosamilia MB, Williams J, Bair CA, Mulder H, Chiswell KE, D'Ottavio AA, Hartman RJ, Sang CJ Jr, Welke KF, Walsh MJ, Hoffman TM, Landstrom AP, Li JS, and Sarno LA
- Subjects
- Humans, Male, Female, Child, Preschool, Risk Factors, Infant, Child, North Carolina epidemiology, Health Services Accessibility, Retrospective Studies, Patient Acceptance of Health Care statistics & numerical data, Infant, Newborn, Follow-Up Studies, Heart Defects, Congenital therapy
- Abstract
Adults with congenital heart disease (CHD) benefit from cardiology follow-up at recommended intervals of ≤ 2 years. However, benefit for children is less clear given limited studies and unclear current guidelines. We hypothesize there are identifiable risks for gaps in cardiology follow-up in children with CHD and that gaps in follow-up are associated with differences in healthcare utilization. Our cohort included children < 10 years old with CHD and a healthcare encounter from 2008 to 2013 at one of four North Carolina (NC) hospitals. We assessed associations between cardiology follow-up and demographics, lesion severity, healthcare access, and educational isolation (EI). We compared healthcare utilization based on follow-up. Overall, 60.4% of 6,969 children received cardiology follow-up within 2 years of initial encounter, including 53.1%, 58.1%, and 79.0% of those with valve, shunt, and severe lesions, respectively. Factors associated with gaps in care included increased drive time to a cardiology clinic (Hazard Ratio (HR) 0.92/15-min increase), EI (HR 0.94/0.2-unit increase), lesion severity (HR 0.48 for shunt/valve vs severe), and older age (HR 0.95/month if < 1 year old and 0.94/year if > 1 year old; p < 0.05). Children with a care gap subsequently had more emergency department (ED) visits (Rate Ratio (RR) 1.59) and fewer inpatient encounters and procedures (RR 0.51, 0.35; p < 0.05). We found novel factors associated with gaps in care for cardiology follow-up in children with CHD and altered health care utilization with a gap. Our findings demonstrate a need to mitigate healthcare barriers and generate clear cardiology follow-up guidelines for children with CHD., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
9. Impact of Prenatal Diagnosis of Critical Congenital Heart Disease on Preoperative and Postoperative Outcomes.
- Author
-
Dischinger AN, Li JS, Mulder H, Spears T, Chiswell KE, Hoffman TM, Hartman RJ, Walsh MJ, Sang CJ, Sarno LA, Paolillo JA, Welke K, D'Ottavio A, and Sethi NJ
- Subjects
- Infant, Newborn, Pregnancy, Female, Humans, Retrospective Studies, Prenatal Diagnosis, Risk Factors, Cardiac Surgical Procedures adverse effects, Heart Defects, Congenital diagnosis, Heart Defects, Congenital surgery
- Abstract
The objective of this study was to assess the relationship of prenatal diagnosis of critical congenital heart disease (CHD) to preoperative and postoperative patient findings. Retrospective analysis of neonates with critical CHD who underwent cardiothoracic surgery at one of four centers in North Carolina between 2008 and 2013. Surgical data collected by sites for submission to the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) and the North Carolina CHD Lifespan Database were queried. There were 715 patients with STS records; 558 linked to the NC-CHD database. Patients with prenatal diagnosis had a lower incidence of preoperative risk factors, including need for mechanical ventilation and presence of shock. However, prenatally diagnosed patients had worse short-term outcomes, including higher operative mortality, higher incidence of select postoperative complications, and longer LOS. There was no difference in one-year mortality. Our findings are consistent with current literature which suggests that prenatal diagnosis of critical CHD is associated with a more optimized preoperative clinical status. However, we found that patients with prenatal diagnoses had less favorable postoperative outcomes. This needs to be investigated further, but may be secondary to patient-specific factors, such as CHD disease severity., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
10. Single-drug immunosuppression is associated with noninferior medium-term survival in pediatric heart transplant recipients.
- Author
-
Watelle L, Touré M, Lamour JM, Kemna MS, Spinner JA, Hoffman TM, Carlo WF, Ballweg JA, Greenway SC, and Dallaire F
- Subjects
- Child, Humans, Retrospective Studies, Immunosuppressive Agents therapeutic use, Immunosuppression Therapy, Cohort Studies, Graft Rejection epidemiology, Graft Rejection prevention & control, Graft Rejection etiology, Transplant Recipients, Heart Transplantation, Heart Diseases
- Abstract
Background: Patients are usually maintained on at least 2 immunosuppressive drugs (ISDs) after the first year post heart transplant. Anecdotally, some children are switched to single-drug monotherapy (a single ISD) for various reasons and varying durations. Outcomes associated with differences in immunosuppression after heart transplantation are unknown for children., Objectives: A priori we defined a noninferiority hypothesis for monotherapy compared to ≥2 ISDs. The primary outcome was graft failure, a composite of death and retransplantation. Secondary outcomes included rejection, infection, malignancy, cardiac allograft vasculopathy and dialysis., Methods: This international, multicenter, retrospective, observational cohort study used data from the Pediatric Heart Transplant Society. We included patients who underwent first-time heart transplant <18 years of age between 1999 and 2020 with ≥1 year of follow-up data available., Results: Our analysis included 3493 patients with a median time post-transplant of 6.7 years. There were 893 patients (25.6%) switched to monotherapy at least once with the remaining 2600 patients always on ≥2 ISDs. The median time on monotherapy after the first year post-transplant was 2.8 years (range 1.1-5.9 years). We found an adjusted hazard ratio (HR) of 0.65 (95%CI: 0.47-0.88) favoring monotherapy compared to ≥2 ISDs (p = 0.002). There were no meaningful differences in the incidence of secondary outcomes between groups, except for a lower rate of cardiac allograft vasculopathy in patients on monotherapy (HR 0.58, 95%CI: 0.45-0.74)., Conclusions: For pediatric heart transplant recipients placed on monotherapy, immunosuppression with a single ISD after the first year post-transplant was noninferior to standard therapy with ≥2 ISDs in the medium term., Condensed Abstract: Some children are switched to a single immunosuppressive drug (ISD) for various reasons after heart transplant, but outcomes associated with differences in immunosuppression are unknown for children. We assessed graft failure in children on a single ISD (monotherapy) compared to ≥2 ISDs in a cohort of 3493 children with a first heart transplant. We found an adjusted hazard ratio of 0.65 (95%CI: 0.47-0.88) favoring monotherapy. We concluded that for pediatric heart transplant recipients placed on monotherapy, immunosuppression with a single ISD after the first year post-transplant was non-inferior to standard therapy with ≥2 ISDs in the medium term., Competing Interests: Disclosure statement This study was partially funded by an unresticted grant from the Foundation of Stars, Montreal, Canada. F.D. is a research scholar with salary support from the Fonds de recherche du Québec – Santé (grant #281946). The authors have no conflicts of interest to disclose., (Copyright © 2023 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
11. The Fontan immunophenotype and post-transplant outcomes in children: A multi-institutional study.
- Author
-
Mantell BS, Azeka E, Cantor RS, Carlo WF, Chrisant M, Dykes JC, Hoffman TM, Kirklin JK, Koehl D, L'Ecuyer TJ, McAllister JM, Prada-Ruiz AC, and Richmond ME
- Subjects
- Child, Humans, Immunosuppression Therapy adverse effects, Retrospective Studies, Protein-Losing Enteropathies etiology, Lymphopenia complications, Fontan Procedure adverse effects, Heart Transplantation, Bone Marrow Diseases, Neoplasms complications
- Abstract
Background: Patients after Fontan palliation represent a growing pediatric population requiring heart transplant (HTx) and often have lymphopenia (L) and/or hypogammaglobinemia that may be exacerbated by protein-losing enteropathy (PLE, P). The post-HTx effects of this altered immune phenotype are not well studied., Methods: In this study of the Pediatric Heart Transplant Society Registry, 106 Fontan patients who underwent HTx between 2005 and 2018 were analyzed. The impact of lymphopenia and PLE on graft survival, infection, rejection, and malignancy was analyzed at 1 and 5 years post-HTx., Results: The following combinations of lymphopenia and PLE were noted: +L+P, n = 37; +L-P, n = 23; -L+P, n = 10; and -L-P, n = 36. Graft survival between the groups was similar within the first year after transplant (+L+P: 86%, +L-P: 86%, -L+P: 87%, -L-P: 89%, p = .9). Freedom from first infection post-HTx was greatest among -L-P patients compared to patients with either PLE, lymphopenia, or both; with a 22.1% infection incidence in the -L-P group and 41.4% in all others. These patients had a significantly lower infection rate in the first year after HTx (+L+P: 1.03, +L-P: 1, -L+P: 1.3, -L-P: 0.3 infections/year, p < .001) and were similar to a non-single ventricle CHD control group (0.4 infections/year). Neither freedom from rejection nor freedom from malignancy 1 and 5 years post-HTx, differed among the groups., Conclusions: Fontan patients with altered immunophenotype, with lymphopenia and/or PLE, are at increased risk of infection post-HTx, although have similar early survival and freedom from rejection and malignancy. These data may encourage alternative immunosuppression strategies and enhanced monitoring for this growing subset of patients., (© 2022 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
12. Initial Counseling Prior to Palliation for Hypoplastic Left Heart Syndrome: 2021 vs 2011.
- Author
-
Nandi D, Culp S, Yates AR, Hoffman TM, Juraszek AL, Snyder CS, Feltes TF, and Cua CL
- Subjects
- Infant, Child, Humans, Female, Male, Pulmonary Artery surgery, Heart Ventricles, Counseling, Treatment Outcome, Retrospective Studies, Hypoplastic Left Heart Syndrome surgery, Blalock-Taussig Procedure methods, Heart Transplantation, Norwood Procedures methods
- Abstract
We sought to examine current practices and changes in practice regarding initial counseling for families of patients with hypoplastic left heart syndrome (HLHS) given the evolution of options and outcomes over time. Counseling (Norwood with Blalock-Taussig-Thomas shunt (NW-BTT), NW with right ventricle to pulmonary artery conduit (NW-RVPA), hybrid palliation, heart transplantation, or non-intervention/hospice (NI)) for patients with HLHS were queried via questionnaire of pediatric care professionals in 2021 and compared to identical questionnaire from 2011. Of 322 respondents in 2021 (39% female), 299 respondents were cardiologists (92.9%), 17cardiothoracic surgeons (5.3%), and 6 were nurse practitioners (1.9%). Respondents were largely from North America (96.9%). In 2021, NW-RVPA procedure was the preferred palliation for standard risk HLHS patient (61%) and was preferred across all US regions (p < 0.001). NI was offered as an option by 71.4% of respondents for standard risk patients and was the predominant strategy for patients with end-organ dysfunction, chromosomal abnormality, and prematurity (52%, 44%, and 45%, respectively). The hybrid procedure was preferred for low birth-weight infants (51%). In comparison to the identical 2011 questionnaire (n = 200), the NW-RVPA was endorsed more in 2021 (61% vs 52%, p = 0.04). For low birth-weight infants, hybrid procedure was more recommended than in 2011 (51% vs 21%, p < 0.001). The NW-RVPA operation is the most recommended strategy throughout the US for infants with HLHS. The hybrid procedure for low birth-weight infants is increasingly recommended. NI continues to be offered even in standard risk patients with HLHS., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
13. Worsening racial disparity in waitlist mortality for pediatric heart transplant candidates since the 2016 Pediatric Heart Allocation Policy revision.
- Author
-
Wright LK, Gajarski RJ, Phelps C, Hoffman TM, Lytrivi ID, Magnetta DA, Shaw FR, Thompson C, Weisert M, and Nandi D
- Subjects
- Humans, Child, Waiting Lists, Policy, Retrospective Studies, Heart Transplantation, Cardiomyopathies
- Abstract
Background: The US Pediatric Heart Allocation Policy (PHAP) was revised in March 2016, with the goal of reducing waitlist mortality. We evaluated the hypothesis that these changes, which increased status exceptions, have worsened racial disparities in waitlist outcomes., Methods: Children in the Pediatric Heart Transplant Study database listed for first heart transplant from January 2012 - June 2020 were included and stratified by listing before (Era 1) or after (Era 2) the PHAP revision., Results: A total of 4,089 children were listed during the study period. Compared with white children (n = 2648), non-white children (n = 1441) were more likely to have an underlying diagnosis of cardiomyopathy in both eras. Waitlist mortality was similar in white and non-white children in Era 1, but comparatively worse for non-white children in Era 2. In multivariable analysis controlling for diagnosis, age, and severity markers, non-white children had a significantly higher waitlist mortality only in Era 2 (Era 1: sHR 1.22 [95%CI 0.90 - 1.66] vs. Era 2: sHR 1.57 [95%CI 1.17 - 2.10])., Conclusions: Widening racial disparities in waitlist mortality may be an unintended consequence of the 2016 PHAP revision. Additional analyses may inform the degree to which this policy vs. unrelated changes in care differentially contribute to these disparities., (© 2022 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF
14. Third-Grade Academic Performance and Episodes of Cardiac Care Among Children with Congenital Heart Defects.
- Author
-
Watkins S, Kemper AR, D'Ottavio A, Hoffman TM, Hartman RJ, Sang CJ, Sarno L, Paolillo J, Welke KF, Walsh MJ, Forestieri N, and Li JS
- Subjects
- Humans, Child, Educational Status, Schools, North Carolina epidemiology, Academic Performance, Heart Defects, Congenital epidemiology, Heart Defects, Congenital therapy
- Abstract
Children with congenital heart defects (CHDs) are at risk for poor academic performance. The degree to which receipt of health care services is associated with adverse academic outcomes is not known. We examined the association between episodes of cardiac care and third-grade performance in children with CHD. We identified subjects between 1/1/2008 and 4/30/2012 among 5 centers in North Carolina. We classified children by CHD type and linked subjects to the state educational records. Any inpatient or outpatient cardiac encounter on a date of service was considered an encounter. We calculated the number of encounters by adding the number of inpatient or outpatient cardiac visits prior to the date of the end-of-grade (EOG) tests. We estimated the odds of failing third-grade reading or math EOG tests by episodes of care stratified at the 50th percentile, controlling for CHD type, maternal education, sex, race/ethnicity, birth weight, and gestational age. A total of 184 children had third-grade EOG scores linked to health care records. The median number of episodes of care was 4 (range: 1-60). Those with visits ˃ 50th percentile (> 4 encounters/year over the 4.3 year observation period) had 2.09 (95% CI 1.04, 4.21) greater odds of failing the math EOG compared to those ≤ 50th percentile (1-4 encounters). The third-grade math score declined by 1.5 points (P < 0.008) for every 10 episodes of care. There was no association of episodes of care on third-grade reading performance. Children with CHD with > 4 episodes of cardiac care/year may be at risk for delays in third-grade academic performance. Strategies to minimize school absenteeism may improve academic success in this population., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
15. The Journey to a Negative Fluid Balance in Pediatric Cardiac Critical Care.
- Author
-
Hoffman TM
- Subjects
- Child, Humans, Fluid Therapy, Intensive Care Units, Pediatric, Critical Illness, Water-Electrolyte Balance, Critical Care
- Published
- 2022
- Full Text
- View/download PDF
16. Disparities in Loss to Follow-Up Among Adults With Congenital Heart Disease in North Carolina.
- Author
-
Serfas JD, Spates T, D'Ottavio A, Spears T, Ciociola E, Chiswell K, Davidson-Ray L, Ryan G, Forestieri N, Krasuski RA, Kemper AR, Hoffman TM, Walsh MJ, Sang CJ, Welke KF, and Li JS
- Subjects
- Adult, Humans, Female, Adolescent, Male, Follow-Up Studies, North Carolina epidemiology, Risk Factors, Heart Defects, Congenital epidemiology, Heart Defects, Congenital surgery, Cardiology
- Abstract
Background: The AHA/ACC Adult Congenital Heart Disease guidelines recommend that most adults with congenital heart disease (CHD) follow-up with CHD cardiologists every 1 to 2 years because longer gaps in care are associated with adverse outcomes. This study aimed to determine the proportion of patients in North Carolina who did not have recommended follow-up and to explore predictors of loss to follow-up., Methods: Patients ages ≥18 years with a healthcare encounter from 2008 to 2013 in a statewide North Carolina database with an ICD-9 code for CHD were assessed. The proportion with cardiology follow-up within 24 months following index encounter was assessed with Kaplan-Meier estimates. Cox regression was utilized to identify demographic factors associated with differences in follow-up., Results: 2822 patients were identified. Median age was 35 years; 55% were female. 70% were white, 22% black, and 3% Hispanic; 36% had severe CHD. The proportion with 2-year cardiology follow-up was 61%. Those with severe CHD were more likely to have timely follow-up than those with less severe CHD (72% vs 55%, P < .01). Black patients had a lower likelihood of follow-up than white patients (56% vs 64%, P = .01). Multivariable Cox regression identified younger age, non-severe CHD, and non-white race as risk factors for a lower likelihood of follow-up by 2 years., Conclusion: 39% of adults with CHD in North Carolina are not meeting AHA/ACC recommendations for follow-up. Younger and minority patients and those with non-severe CHD were particularly vulnerable to inadequate follow-up; targeted efforts to retain these patients in care may be helpful.
- Published
- 2022
- Full Text
- View/download PDF
17. Standardized Training for Physicians Practicing Pediatric Cardiac Critical Care.
- Author
-
Tabbutt S, Krawczeski C, McBride M, Amirnovin R, Owens G, Smith A, Wolf M, Rhodes L, Hehir D, Asija R, Teele SA, Ghanayem N, Zyblewski S, Thiagarajan R, Yeh J, Shin AY, Schwartz SM, Schuette J, Scahill C, Roth SJ, Hoffman TM, Cooper DS, Byrnes J, Bergstrom C, Vesel T, Scott JP, Rossi A, Kwiatkowski D, DiPietro LM, Connor C, Chen J, Charpie J, Bochkoris M, Affolter J, and Bronicki RA
- Subjects
- Child, Critical Care, Curriculum, Education, Medical, Graduate, Humans, Infant, Newborn, United States, Pediatrics, Physicians
- Abstract
Objectives: In the vast majority of Children's Hospitals, the critically ill patient can be found in one of three locations: the PICU, the neonatal ICU, and the cardiac ICU. Training, certification, and maintenance of certification for neonatology and critical care medicine are over seen by the Accreditation Council for Graduate Medical Education and American Board of Pediatrics. There is no standardization of training or oversight of certification and maintenance of certification for pediatric cardiac critical care., Data Sources: The curricula from the twenty 4th year pediatric cardiac critical care training programs were collated, along with the learning objectives from the Pediatric Cardiac Intensive Care Society published "Curriculum for Pediatric Cardiac Critical Care Medicine.", Study Selection: This initiative is endorsed by the Pediatric Cardiac Intensive Care Society as a first step toward Accreditation Council for Graduate Medical Education oversight of training and American Board of Pediatrics oversight of maintenance of certification., Data Extraction: A taskforce was established of cardiac intensivists, including the directors of all 4th year pediatric cardiac critical care training programs., Data Synthesis: Using modified Delphi methodology, learning objectives, rotational requirements, and institutional requirements for providing training were developed., Conclusions: In the current era of increasing specialized care in pediatric cardiac critical care, standardized training for pediatric cardiac critical care is paramount to optimizing outcomes., Competing Interests: Dr. McBride received funding from the American Heart Association. Dr. Smith received funding from Huff Powell Bailey, LLC. Dr. Thiagarajan’s institution received funding from Pfizer and Bristol Myers Squibb; he received funding from Advocate. The remaining authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2021 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.)
- Published
- 2022
- Full Text
- View/download PDF
18. Causes of Death in Infants and Children with Congenital Heart Disease.
- Author
-
Williams JL, Torok RD, D'Ottavio A, Spears T, Chiswell K, Forestieri NE, Sang CJ, Paolillo JA, Walsh MJ, Hoffman TM, Kemper AR, and Li JS
- Subjects
- Adolescent, Child, Child, Preschool, Female, Humans, Infant, Infant, Newborn, Male, North Carolina epidemiology, Young Adult, Cause of Death trends, Heart Defects, Congenital mortality
- Abstract
With improved surgical outcomes, infants and children with congenital heart disease (CHD) may die from other causes of death (COD) other than CHD. We sought to describe the COD in youth with CHD in North Carolina (NC). Patients from birth to 20 years of age with a healthcare encounter between 2008 and 2013 in NC were identified by ICD-9 code. Patients who could be linked to a NC death certificate between 2008 and 2016 were included. Patients were divided by CHD subtypes (severe, shunt, valve, other). COD was compared between groups. Records of 35,542 patients < 20 years old were evaluated. There were 15,277 infants with an annual mortality rate of 3.5 deaths per 100 live births. The most frequent COD in infants (age < 1 year) were CHD (31.7%), lung disease (16.1%), and infection (11.4%). In 20,265 children (age 1 to < 20 years), there was annual mortality rate of 9.7 deaths per 1000 at risk. The most frequent COD in children were CHD (34.2%), neurologic disease (10.2%), and infection (9.5%). In the severe subtype, CHD was the most common COD. In infants with shunt-type CHD disease, lung disease (19.5%) was the most common COD. The mortality rate in infants was three times higher when compared to children. CHD is the most common underlying COD, but in those with shunt-type lesions, extra-cardiac COD is more common. A multidisciplinary approach in CHD patients, where development of best practice models regarding comorbid conditions such as lung disease and neurologic disease could improve outcomes in this patient population., (© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
19. Causes of Death and Cardiovascular Comorbidities in Adults With Congenital Heart Disease.
- Author
-
Goldstein SA, D'Ottavio A, Spears T, Chiswell K, Hartman RJ, Krasuski RA, Kemper AR, Meyer RE, Hoffman TM, Walsh MJ, Sang CJ, Paolillo J, and Li JS
- Subjects
- Aged, Aged, 80 and over, Cohort Studies, Comorbidity, Female, Humans, Male, North Carolina epidemiology, Risk Factors, Cause of Death, Heart Defects, Congenital mortality
- Abstract
Background Little is known about the contemporary mortality experience among adults with congenital heart disease (CHD). The objectives of this study were to assess the age at death, presence of cardiovascular comorbidities, and most common causes of death among adults with CHD in a contemporary cohort within the United States. Methods and Results Patients with CHD who had a healthcare encounter between 2008 and 2013 at 1 of 5 comprehensive CHD centers in North Carolina were identified by International Classification of Diseases, Ninth Revision ( ICD-9 ), code. Only patients who could be linked to a North Carolina death certificate between 2008 and 2016 and with age at death ≥20 years were included. Median age at death and underlying cause of death based on death certificate data were analyzed. The prevalence of acquired cardiovascular risk factors was determined from electronic medical record data. Among the 629 included patients, the median age at death was 64.2 years. Those with severe CHD (n=157, 25%), shunts (n=202, 32%), and valvular lesions (n=174, 28%) had a median age at death of 46.0, 65.0, and 73.3 years, respectively. Cardiovascular death was most common in adults with severe CHD (60%), with 40% of those deaths caused by CHD. Malignancy and ischemic heart disease were the most common causes of death in adults with nonsevere CHD. Hypertension and hyperlipidemia were common comorbidities among all CHD severity groups. Conclusions The most common underlying causes of death differed by lesion severity. Those with severe lesions most commonly died from underlying CHD, whereas those with nonsevere disease more commonly died from non-CHD causes.
- Published
- 2020
- Full Text
- View/download PDF
20. Orthotopic Heart Transplantation in a Patient With Gitelman Syndrome and Dilated Cardiomyopathy.
- Author
-
Solt SA, Hoffman TM, Sharma MS, Westreich KD, Kihlstrom M, and Schwartz SP
- Subjects
- Cardiomyopathy, Dilated complications, Cardiomyopathy, Dilated diagnosis, Child, Echocardiography, Gitelman Syndrome complications, Gitelman Syndrome diagnosis, Humans, Male, Tomography, X-Ray Computed, Cardiomyopathy, Dilated surgery, Gitelman Syndrome surgery, Heart Transplantation methods
- Abstract
Gitelman syndrome (GS) is a rare hereditary tubulopathy affecting the distal tubule leading to significant electrolyte disturbances.
1 Although generally a benign condition, rare associations with arrhythmias and sudden cardiac death have been reported.1 A paucity of literature exists associating GS with cardiomyopathy. We present a child with dilated cardiomyopathy and GS who was successfully treated with orthotopic heart transplantation.- Published
- 2020
- Full Text
- View/download PDF
21. Decompression of the thoracic duct: A novel transcatheter approach.
- Author
-
Smith CL, Hoffman TM, Dori Y, and Rome JJ
- Subjects
- Bronchitis diagnosis, Bronchitis etiology, Bronchitis physiopathology, Cardiac Catheters, Child, Heart Defects, Congenital diagnostic imaging, Heart Defects, Congenital physiopathology, Hemodynamics, Humans, Lymphatic Diseases diagnostic imaging, Lymphatic Diseases etiology, Lymphatic Diseases physiopathology, Male, Palliative Care, Protein-Losing Enteropathies diagnosis, Protein-Losing Enteropathies etiology, Protein-Losing Enteropathies physiopathology, Stents, Thoracic Duct diagnostic imaging, Treatment Outcome, Bronchitis therapy, Cardiac Catheterization instrumentation, Fontan Procedure adverse effects, Heart Defects, Congenital surgery, Lymphatic Diseases therapy, Protein-Losing Enteropathies therapy, Thoracic Duct physiopathology
- Abstract
In patients with total cavopulmonary connections, elevated central venous pressures (CVP) have detrimental effects on the lymphatic system causing an imbalance in fluid production and drainage of the interstitium. This combination may result in life-threatening lymphatic complications including plastic bronchitis (PB), protein losing enteropathy (PLE), chylothorax, and ascites. While embolization of the abnormal lymphatics has greatly improved outcomes from these complications, alternative treatment strategies have been proposed that would result in improved lymphatic drainage while leaving the lymphatic system intact. We report two novel transcatheter approaches for thoracic duct (TD) decompression in two patients who developed PLE after completion of the Fontan procedure as part of staged palliation for congenital heart disease. In addition, one patient had severe concurrent PB. In both patients, a connection was created between a left superior vena cava (LSVC) to the left atrium allowing for a nonsurgical method to decompress the TD. This procedure resulted in significant clinical and laboratory improvement of both patients' PLE and other symptoms of lymphatic dysfunction., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2020
- Full Text
- View/download PDF
22. Renal injury and recovery in pediatric patients after ventricular assist device implantation and cardiac transplant.
- Author
-
Hollander SA, Cantor RS, Sutherland SM, Koehl DA, Pruitt E, McDonald N, Kirklin JK, Ravekes WJ, Ameduri R, Chrisant M, Hoffman TM, Lytrivi ID, and Conway J
- Subjects
- Adolescent, Child, Child, Preschool, Female, Glomerular Filtration Rate, Humans, Male, Recovery of Function, Registries, Risk Factors, United States epidemiology, Acute Kidney Injury epidemiology, Heart Transplantation, Heart-Assist Devices, Kidney Failure, Chronic epidemiology, Postoperative Complications epidemiology
- Abstract
Background: The use of ventricular assist devices (VADs) in children with heart failure may be of particular benefit to those with accompanying renal failure, as improved renal function is seen in some, but not all recipients. We hypothesized that persistent renal dysfunction at 7 days and/or 1 month after VAD implantation would predict chronic kidney disease (CKD) 1 year after heart transplantation (HT)., Methods: Linkage analysis of all VAD patients enrolled in both the PEDIMACS and PHTS registries between 2012 and 2016. Persistent acute kidney injury (P-AKI), defined as a serum creatinine ≥1.5× baseline, was assessed at post-implant day 7. Estimated glomerular filtration rate (eGFR) was determined at implant, 30 days thereafter, and 12 months post-HT. Pre-implant eGFR, eGFR normalization (to ≥90 mL/min/1.73 m
2 ), and P-AKI were used to predict post-HT CKD (eGFR <90 mL/min/1.73 m2 )., Results: The mean implant eGFR was 85.4 ± 46.5 mL/min/1.73 m2 . P-AKI was present in 19/188 (10%). Mean eGFR at 1 month post-VAD implant was 131.1 ± 62.1 mL/min/1.73 m2 , significantly increased above baseline (P < 0.001). At 1 year post-HT (n = 133), 60 (45%) had CKD. Lower pre-implant eGFR was associated with post-HT CKD (OR 0.99, CI: 0.97-0.99, P = 0.005); P-AKI was not (OR 0.96, CI: 0.3-3.0, P = 0.9). Failure to normalize renal function 30 days after implant was highly associated with CKD at 1 year post-transplant (OR 12.5, CI 2.8-55, P = 0.003)., Conclusions: Renal function improves after VAD implantation. Lower pre-implant eGFR and failure to normalize renal function during the support period are risk factors for CKD development after HT., (© 2019 Wiley Periodicals, Inc.)- Published
- 2019
- Full Text
- View/download PDF
23. Home Oxygen Therapy for Children. An Official American Thoracic Society Clinical Practice Guideline.
- Author
-
Hayes D Jr, Wilson KC, Krivchenia K, Hawkins SMM, Balfour-Lynn IM, Gozal D, Panitch HB, Splaingard ML, Rhein LM, Kurland G, Abman SH, Hoffman TM, Carroll CL, Cataletto ME, Tumin D, Oren E, Martin RJ, Baker J, Porta GR, Kaley D, Gettys A, and Deterding RR
- Subjects
- Child, Child, Preschool, Humans, Infant, Societies, United States, Home Care Services, Oxygen Inhalation Therapy methods, Respiration Disorders therapy
- Abstract
Background: Home oxygen therapy is often required in children with chronic respiratory conditions. This document provides an evidence-based clinical practice guideline on the implementation, monitoring, and discontinuation of home oxygen therapy for the pediatric population., Methods: A multidisciplinary panel identified pertinent questions regarding home oxygen therapy in children, conducted systematic reviews of the relevant literature, and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach to rate the quality of evidence and strength of clinical recommendations., Results: After considering the panel's confidence in the estimated effects, the balance of desirable (benefits) and undesirable (harms and burdens) consequences of treatment, patient values and preferences, cost, and feasibility, recommendations were developed for or against home oxygen therapy specific to pediatric lung and pulmonary vascular diseases., Conclusions: Although home oxygen therapy is commonly required in the care of children, there is a striking lack of empirical evidence regarding implementation, monitoring, and discontinuation of supplemental oxygen therapy. The panel formulated and provided the rationale for clinical recommendations for home oxygen therapy based on scant empirical evidence, expert opinion, and clinical experience to aid clinicians in the management of these complex pediatric patients and identified important areas for future research.
- Published
- 2019
- Full Text
- View/download PDF
24. Bacterial infections after pediatric heart transplantation: Epidemiology, risk factors and outcomes.
- Author
-
Rostad CA, Wehrheim K, Kirklin JK, Naftel D, Pruitt E, Hoffman TM, L'Ecuyer T, Berkowitz K, Mahle WT, and Scheel JN
- Subjects
- Adolescent, Age Distribution, Bacterial Infections therapy, Child, Child, Preschool, Cohort Studies, Confidence Intervals, Databases, Factual, Female, Heart Transplantation methods, Heart Transplantation mortality, Humans, Incidence, Male, Multivariate Analysis, Outcome Assessment, Health Care, Postoperative Complications epidemiology, Postoperative Complications microbiology, Postoperative Complications physiopathology, Proportional Hazards Models, Retrospective Studies, Severity of Illness Index, Sex Distribution, Survival Analysis, United States epidemiology, Bacterial Infections diagnosis, Bacterial Infections epidemiology, Cause of Death, Heart Transplantation adverse effects
- Abstract
Background: Bacterial infections represent a major cause of morbidity and mortality in heart transplant recipients. However, data describing the epidemiology and outcomes of these infections in children are limited., Methods: We analyzed the Pediatric Heart Transplant Study database of patients transplanted between 1993 and 2014 to determine the etiologies, risk factors and outcomes of children with bacterial infections post-heart transplantation., Results: Of 4,458 primary transplants in the database, there were 4,815 infections that required hospitalization or intravenous therapy, 2,047 (42.51%) of which were bacterial. The risk of bacterial infection was highest in the first month post-transplant, and the bloodstream was the most common site (24.82%). In the early post-transplant period (<30 days post-transplant), coagulase-negative staphylococci were the most common pathogens (16.97%), followed by Enterobacter sp (11.99%) and Pseudomonas sp (11.62%). In the late post-transplant period, community-acquired pathogens Streptococcus pneumoniae (6.27%) and Haemophilus influenzae (2.82%) were also commonly identified. Patients' characteristics independently associated with acquisition of bacterial infection included younger age (p < 0.0001) and ventilator (p < 0.0001) or extracorporeal membrane oxygenation (p = 0.03) use at time of transplant. Overall mortality post-bacterial infection was 33.78%, and previous cardiac surgery (p < 0.001) and multiple sites of infection (p = 0.004) were independent predictors of death., Conclusions: Bacteria were the most common causes of severe infections in pediatric heart transplant recipients and were associated with high mortality rates. The risk of acquiring a bacterial infection was highest in the first month post-transplant, and a large proportion of the infections were caused by multidrug-resistant pathogens., (Copyright © 2017 International Society for the Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
25. Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement From the American Heart Association.
- Author
-
Cook JL, Colvin M, Francis GS, Grady KL, Hoffman TM, Jessup M, John R, Kiernan MS, Mitchell JE, Pagani FD, Petty M, Ravichandran P, Rogers JG, Semigran MJ, and Toole JM
- Subjects
- Disease-Free Survival, Female, Heart Failure mortality, Heart Failure physiopathology, Heart Failure therapy, Humans, Male, Practice Guidelines as Topic, Survival Rate, United States epidemiology, United States Food and Drug Administration, American Heart Association, Assisted Circulation instrumentation, Assisted Circulation methods, Device Approval, Extracorporeal Circulation instrumentation, Extracorporeal Circulation methods
- Abstract
Competing Interests: The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.
- Published
- 2017
- Full Text
- View/download PDF
26. Abnormalities in serum biomarkers correlate with lower cardiac index in the Fontan population.
- Author
-
Marino BS, Goldberg DJ, Dorfman AL, King E, Kalkwarf H, Zemel BS, Smith M, Pratt J, Fogel MA, Shillingford AJ, Deal BJ, John AS, Goldberg CS, Hoffman TM, Jacobs ML, Lisec A, Finan S, Kochilas LK, Pawlowski TW, Campbell K, Joiner C, Goldstein SL, Stephens P, and Chin AJ
- Subjects
- Adolescent, Adult, Child, Female, Follow-Up Studies, Heart Defects, Congenital physiopathology, Heart Defects, Congenital surgery, Humans, Male, Prognosis, Prospective Studies, ROC Curve, Young Adult, Biomarkers blood, Cardiac Output physiology, Fontan Procedure methods, Heart Defects, Congenital blood, Monitoring, Physiologic methods
- Abstract
Background: Fontan survivors have depressed cardiac index that worsens over time. Serum biomarker measurement is minimally invasive, rapid, widely available, and may be useful for serial monitoring. The purpose of this study was to identify biomarkers that correlate with lower cardiac index in Fontan patients. Methods and results This study was a multi-centre case series assessing the correlations between biomarkers and cardiac magnetic resonance-derived cardiac index in Fontan patients ⩾6 years of age with biochemical and haematopoietic biomarkers obtained ±12 months from cardiac magnetic resonance. Medical history and biomarker values were obtained by chart review. Spearman's Rank correlation assessed associations between biomarker z-scores and cardiac index. Biomarkers with significant correlations had receiver operating characteristic curves and area under the curve estimated. In total, 97 cardiac magnetic resonances in 87 patients met inclusion criteria: median age at cardiac magnetic resonance was 15 (6-33) years. Significant correlations were found between cardiac index and total alkaline phosphatase (-0.26, p=0.04), estimated creatinine clearance (0.26, p=0.02), and mean corpuscular volume (-0.32, p<0.01). Area under the curve for the three individual biomarkers was 0.63-0.69. Area under the curve for the three-biomarker panel was 0.75. Comparison of cardiac index above and below the receiver operating characteristic curve-identified cut-off points revealed significant differences for each biomarker (p<0.01) and for the composite panel [median cardiac index for higher-risk group=2.17 L/minute/m2 versus lower-risk group=2.96 L/minute/m2, (p<0.01)]., Conclusions: Higher total alkaline phosphatase and mean corpuscular volume as well as lower estimated creatinine clearance identify Fontan patients with lower cardiac index. Using biomarkers to monitor haemodynamics and organ-specific effects warrants prospective investigation.
- Published
- 2017
- Full Text
- View/download PDF
27. A multi-institutional evaluation of antibody-mediated rejection utilizing the Pediatric Heart Transplant Study database: Incidence, therapies and outcomes.
- Author
-
Thrush PT, Pahl E, Naftel DC, Pruitt E, Everitt MD, Missler H, Zangwill S, Burch M, Hoffman TM, Butts R, and Mahle WT
- Subjects
- Antibodies, Child, Graft Rejection, Humans, Incidence, Kidney Transplantation, Retrospective Studies, Heart Transplantation
- Abstract
Background: Current knowledge of antibody-mediated rejection (AMR) after heart transplantation (HT) stems largely from adult data. Using the Pediatric Heart Transplant Study (PHTS) database, we report the incidence of AMR, describe treatment, and evaluate outcomes for treated AMR in children after HT., Methods: We queried the PHTS database for patients <18 years of age undergoing primary HT between January 2010 and December 2014. An AMR episode was defined as either a biopsy consistent with pathologic AMR or a rejection event based on immunotherapy augmentation directed against antibody production. Biopsy data, treatment strategies and survival were analyzed., Results: An episode of AMR was identified in 179 of 1,596 (11%) HT recipients and in 246 of 705 (35%) rejection episodes. AMR was diagnosed by biopsy in 182 of 246 episodes and by immunotherapy in 64 of 179 episodes. Mixed rejection was identified in 179. Freedom from AMR was 88% and 82% at 1 and 3 years, respectively. AMR therapies included intravenous immunoglobulin (IVIg) (58%), plasmapheresis (40%), rituximab (40%), bortezomib (11%) and eculizumab (0.4%). The most commonly used combination therapies included IVIg/plasmapheresis/rituximab (13%). Thirty-three patients (16%) died after developing AMR. Patient and graft survival were lower for the AMR
+ group. One- and 3-year survival after initial AMR diagnosis was 88% and 77%, respectively., Conclusions: In his study we report the largest experience of AMR in pediatric HT recipients. AMR was common and often occurred concurrently with acute cellular rejection. There is wide variability in the treatment of AMR. Short-term patient and graft outcomes were worse for those with treated AMR., (Copyright © 2016 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)- Published
- 2016
- Full Text
- View/download PDF
28. Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy?
- Author
-
Mills KI, Vincent JA, Zuckerman WA, Hoffman TM, Canter CE, Marshall AC, Blume ED, Bergersen L, and Daly KP
- Subjects
- Biopsy, Child, Endocardium, Humans, Myocarditis, Myocardium, Retrospective Studies, Cardiomyopathies
- Abstract
Endomyocardial biopsy (EMB) is a common procedure used to aid in the diagnosis, prognosis and treatment of suspected pediatric cardiomyopathy. In suspected cardiomyopathy, no multicenter experience has previously reported on the safety and utility of EMBs. Retrospectively, adverse event (AE) and patient and procedural characteristics were obtained at seven institutions participating in the Congenital Cardiac Catheterization Outcomes Project for both a cardiomyopathy (n = 158) and a post-transplant surveillance (n = 2665) cohort. Descriptive information regarding biopsy indication, pathology and clinical management based on EMB findings were retrospectively obtained. High-severity AEs were more common in the cardiomyopathy cohort when compared to the post-transplant surveillance cohort. The cardiomyopathy cohort was younger, more hemodynamically vulnerable and required more cardiorespiratory support during the procedure. The eight high-severity AEs in the cardiomyopathy group included one myocardial perforation, two ECMO cannulations and three deaths following the EMB. Factors associated with high-severity AEs included performing another catheter-based intervention during the EMB and longer fluoroscopy time. Notably, an increased number of biopsy attempts did not increase the risk of an AE. Suspected myocarditis was the most common indication. Diagnostic EMB pathology and thus alteration to clinical management based on pathology occurred more frequently in patients with suspected myocarditis. In conclusion, there is an increased incidence of high-severity AEs in patients undergoing EMB for suspected cardiomyopathy. EMB may be more clinically useful in the management of suspected myocarditis. The increased risk of high-severity AEs when additional interventions are performed highlights the hemodynamic vulnerability in patients with suspected cardiomyopathy.
- Published
- 2016
- Full Text
- View/download PDF
29. Chronic Heart Failure.
- Author
-
Hoffman TM
- Subjects
- Child, Chronic Disease, Disease Management, Heart Failure therapy, Humans, Critical Care methods, Heart Failure etiology
- Abstract
Objectives: The objectives of this review are to discuss the paradigms used to stage heart failure in children, the classification and physiologic profile of cardiomyopathies, and the acute and chronic pharmacologic management of heart failure., Data Source: MEDLINE, PubMed., Conclusion: The etiology of chronic heart failure in pediatrics is vast. The paradigm of extrapolating adult clinical trials and technological advancements to treat heart failure in children has become a nonsustainable model. The field of pediatric heart failure continues to advance with more robust guideline-directed care and the imminent creation of a dynamic, contemporary international database. As the field involves a markedly heterogeneous patient population, it is imperative to use pediatric specific descriptors of disease impact. The fields of pediatric heart failure and critical care medicine will continue to evolve together as childhood specific registries, quality improvement guidelines, and research will lead to practice models eliciting optimal therapy for patients with heart failure in the intensive care setting.
- Published
- 2016
- Full Text
- View/download PDF
30. Clinical Issues and Controversies in Heart Failure and Transplantation.
- Author
-
Rossano JW, Hoffman TM, Jefferies JL, Lorts A, Kirsch RE, and Thiagarajan RR
- Subjects
- Child, Heart-Assist Devices, Humans, Heart Failure therapy, Heart Transplantation, Intensive Care Units
- Abstract
Heart failure is a common problem among children admitted in the intensive care unit and is associated with significant morbidity and mortality. As such, the 2014 meeting of the Pediatric Cardiac Intensive Care Society included a session on Clinical Controversies in Heart Failure and Transplantation. This review contains the summaries of the podium presentations of this session and will cover some of the challenging aspects of caring for these patients including medical and mechanical support, fluid overload states, high-risk populations including those after heart transplantation, and end-of-life considerations., (© The Author(s) 2015.)
- Published
- 2016
- Full Text
- View/download PDF
31. Early versus delayed umbilical cord clamping in infants with congenital heart disease: a pilot, randomized, controlled trial.
- Author
-
Backes CH, Huang H, Cua CL, Garg V, Smith CV, Yin H, Galantowicz M, Bauer JA, and Hoffman TM
- Subjects
- Adult, Constriction, Erythrocyte Transfusion, Female, Gestational Age, Hematocrit, Humans, Infant, Infant, Newborn, Male, Pilot Projects, Pregnancy, Time Factors, Young Adult, Delivery, Obstetric methods, Heart Defects, Congenital blood, Term Birth blood, Umbilical Cord blood supply
- Abstract
Objective: Delayed umbilical cord clamping (DCC) at birth may provide a better neonatal health status than early umbilical cord clamping (ECC). However, the safety and feasibility of DCC in infants with congenital heart disease (CHD) have not been tested. This was a pilot, randomized, controlled trial to establish the safety and feasibility of DCC in neonates with CHD., Study Design: Pregnant women admitted >37 weeks gestational age with prenatal diagnosis of critical CHD were enrolled and randomized to ECC or DCC. For ECC, the umbilical cord was clamped <10 s after birth; for DCC, the cord was clamped ~120 s after delivery., Results: Thirty infants were randomized at birth. No differences between the DCC and ECC groups were observed in gestational age at birth or time of surgery. No differences were observed across all safety measures, although a trend for higher peak serum bilirubin levels (9.2±2.2 vs 7.3±3.2 mg dl(-1), P=0.08) in the DCC group than in the ECC group was noted. Although similar at later time points, hematocrits were higher in the DCC than in the ECC infants during the first 72 h of life. The proportion of infants not receiving blood transfusions throughout hospitalization was higher in the DCC than in the ECC infants (43 vs 7%, log-rank test P=0.02)., Conclusion: DCC in infants with critical CHD appears both safe and feasible, with fewer infants exposed to red blood cell transfusions than with ECC. A more comprehensive appraisal of this practice is warranted., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2015
- Full Text
- View/download PDF
32. Predicting graft loss by 1 year in pediatric heart transplantation candidates: an analysis of the Pediatric Heart Transplant Study database.
- Author
-
Schumacher KR, Almond C, Singh TP, Kirk R, Spicer R, Hoffman TM, Hsu D, Naftel DC, Pruitt E, Zamberlan M, Canter CE, and Gajarski RJ
- Subjects
- Adolescent, Child, Child, Preschool, Databases, Factual, Female, Humans, Infant, Logistic Models, Male, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Cardiomyopathies surgery, Graft Rejection epidemiology, Heart Defects, Congenital surgery, Heart Transplantation, Models, Statistical
- Abstract
Background: Pediatric data on the impact of pre-heart transplantation (HTx) risk factors on early post-HTx outcomes remain inconclusive. Thus, among patients with previous congenital heart disease or cardiomyopathy, disease-specific risk models for graft loss were developed with the use pre-HTx recipient and donor characteristics., Methods and Results: Patients enrolled in the Pediatric Heart Transplant Study (PHTS) from 1996 to 2006 were stratified by pre-HTx diagnosis into cardiomyopathy and congenital heart disease cohorts. Logistic regression identified independent, pre-HTx risk factors. Risk models were constructed for 1-year post-HTx graft loss. Donor factors were added for model refinement. The models were validated with the use of patients transplanted from 2007 to 2009. Risk factors for graft loss were identified in patients with cardiomyopathy (n=896) and congenital heart disease (n=965). For cardiomyopathy, independent risk factors were earlier year of transplantation, nonwhite race, female sex, diagnosis other than dilated cardiomyopathy, higher blood urea nitrogen, and panel reactive antibody >10%. The recipient characteristic risk model had good accuracy in the validation cohort, with predicted versus actual survival of 97.5% versus 95.3% (C statistic, 0.73). For patients with congenital heart disease, independent risk factors were nonwhite race, history of Fontan, ventilator dependence, higher blood urea nitrogen, panel reactive antibody >10%, and lower body surface area. The risk model was less accurate, with 86.6% predicted versus 92.4% actual survival, in the validation cohort (C statistic, 0.63). Donor characteristics did not enhance model precision., Conclusions: Risk factors for 1-year post-HTx graft loss differ on the basis of pre-HTx cardiac diagnosis. Modeling effectively stratifies the risk of graft loss in patients with cardiomyopathy and may be an adjunctive tool in allocation policies and center performance metrics., (© 2015 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
33. Neurodevelopmental outcome after cardiac surgery utilizing cardiopulmonary bypass in children.
- Author
-
Naguib AN, Winch PD, Tobias JD, Yeates KO, Miao Y, Galantowicz M, and Hoffman TM
- Abstract
Introduction: Modulating the stress response and perioperative factors can have a paramount impact on the neurodevelopmental outcome of infants who undergo cardiac surgery utilizing cardiopulmonary bypass., Materials and Methods: In this single center prospective follow-up study, we evaluated the impact of three different anesthetic techniques on the neurodevelopmental outcomes of 19 children who previously underwent congenital cardiac surgery within their 1(st) year of life. Cases were done from May 2011 to December 2013. Children were assessed using the Stanford-Binet Intelligence Scales (5(th) edition). Multiple regression analysis was used to test different parental and perioperative factors that could significantly predict the different neurodevelopmental outcomes in the entire cohort of patients., Results: When comparing the three groups regarding the major cognitive scores, a high-dose fentanyl (HDF) patients scored significantly higher than the low-dose fentanyl (LDF) + dexmedetomidine (DEX) (LDF + DEX) group in the quantitative reasoning scores (106 ± 22 vs. 82 ± 15 P = 0.046). The bispectral index (BIS) value at the end of surgery for the -LDF group was significantly higher than that in LDF + DEX group (P = 0.011). For the entire cohort, a strong correlation was seen between the standard verbal intelligence quotient (IQ) score and the baseline adrenocorticotropic hormone level, the interleukin-6 level at the end of surgery and the BIS value at the end of the procedure with an R(2) value of 0.67 and P < 0.04. There was an inverse correlation between the cardiac Intensive Care Unit length of stay and the full-scale IQ score (R = 0.4675 and P 0.027)., Conclusions: Patients in the HDF group demonstrated overall higher neurodevelopmental scores, although it did not reach statistical significance except in fluid reasoning scores. Our results may point to a possible correlation between blunting the stress response and improvement of the neurodevelopmental outcome.
- Published
- 2015
- Full Text
- View/download PDF
34. Pediatric heart transplantation-indications and outcomes in the current era.
- Author
-
Thrush PT and Hoffman TM
- Abstract
Pediatric heart transplantation (HTx) remains an important treatment option in the care of children with end-stage heart disease, whether it is secondary to cardiomyopathy or congenital heart disease (CHD). As surgical outcomes for CHD have improved, the indications for pediatric HTx have had to be dynamic, not only for children with CHD but also for the growing population of adults with CHD. As the field of pediatric HTx has evolved, the outcomes for children undergoing HTx have improved. This is undoubtedly due to the continued research efforts of both single-center studies, as well as research collaboratives such as the International Society for Heart and Lung Transplantation (ISHLT) and the Pediatric Heart Transplant Study (PHTS) group. Research collaboratives are increasingly important in pediatric HTx as single center studies for a limited patient population may not elicit strong enough evidence for practice evolution. Similarly, complications that limit the long term graft survival may occur in a minority of patients thus pooled experience is essential. This review focuses on the indications and outcomes for pediatric HTx, with a special emphasis on studies generated by these research collaboratives.
- Published
- 2014
- Full Text
- View/download PDF
35. Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.
- Author
-
Pennell DJ, Udelson JE, Arai AE, Bozkurt B, Cohen AR, Galanello R, Hoffman TM, Kiernan MS, Lerakis S, Piga A, Porter JB, Walker JM, and Wood J
- Subjects
- Consensus, Heart Failure physiopathology, Humans, Iron Chelating Agents therapeutic use, Iron Overload complications, Iron Overload drug therapy, United States, American Heart Association, Heart Failure etiology, Heart Failure therapy, beta-Thalassemia complications, beta-Thalassemia drug therapy
- Abstract
This aim of this statement is to report an expert consensus on the diagnosis and treatment of cardiac dysfunction in β-thalassemia major (TM). This consensus statement does not cover other hemoglobinopathies, including thalassemia intermedia and sickle cell anemia, in which a different spectrum of cardiovascular complications is typical. There are considerable uncertainties in this field, with a few randomized controlled trials relating to treatment of chronic myocardial siderosis but none relating to treatment of acute heart failure. The principles of diagnosis and treatment of cardiac iron loading in TM are directly relevant to other iron-overload conditions, including in particular Diamond-Blackfan anemia, sideroblastic anemia, and hereditary hemochromatosis. Heart failure is the most common cause of death in TM and primarily results from cardiac iron accumulation. The diagnosis of ventricular dysfunction in TM patients differs from that in nonanemic patients because of the cardiovascular adaptation to chronic anemia in non-cardiac-loaded TM patients, which includes resting tachycardia, low blood pressure, enlarged end-diastolic volume, high ejection fraction, and high cardiac output. Chronic anemia also leads to background symptomatology such as dyspnea, which can mask the clinical diagnosis of cardiac dysfunction. Central to early identification of cardiac iron overload in TM is the estimation of cardiac iron by cardiac T2* magnetic resonance. Cardiac T2* <10 ms is the most important predictor of development of heart failure. Serum ferritin and liver iron concentration are not adequate surrogates for cardiac iron measurement. Assessment of cardiac function by noninvasive techniques can also be valuable clinically, but serial measurements to establish trends are usually required because interpretation of single absolute values is complicated by the abnormal cardiovascular hemodynamics in TM and measurement imprecision. Acute decompensated heart failure is a medical emergency and requires urgent consultation with a center with expertise in its management. The first principle of management of acute heart failure is control of cardiac toxicity related to free iron by urgent commencement of a continuous, uninterrupted infusion of high-dose intravenous deferoxamine, augmented by oral deferiprone. Considerable care is required to not exacerbate cardiovascular problems from overuse of diuretics or inotropes because of the unusual loading conditions in TM. The current knowledge on the efficacy of removal of cardiac iron by the 3 commercially available iron chelators is summarized for cardiac iron overload without overt cardiac dysfunction. Evidence from well-conducted randomized controlled trials shows superior efficacy of deferiprone versus deferoxamine, the superiority of combined deferiprone with deferoxamine versus deferoxamine alone, and the equivalence of deferasirox versus deferoxamine.
- Published
- 2013
- Full Text
- View/download PDF
36. The role of different anesthetic techniques in altering the stress response during cardiac surgery in children: a prospective, double-blinded, and randomized study.
- Author
-
Naguib AN, Tobias JD, Hall MW, Cismowski MJ, Miao Y, Barry N, Preston T, Galantowicz M, and Hoffman TM
- Subjects
- Adrenocorticotropic Hormone blood, Airway Extubation, Analysis of Variance, Blood Transfusion, Child, Preschool, Cytokines blood, Double-Blind Method, Female, Humans, Infant, Length of Stay, Male, Pain, Postoperative, Prospective Studies, Anesthetics, Intravenous administration & dosage, Cardiopulmonary Bypass methods, Dexmedetomidine administration & dosage, Fentanyl administration & dosage, Heart Defects, Congenital surgery, Stress, Physiological drug effects
- Abstract
Objectives: Our goal was to evaluate the role of three anesthetic techniques in altering the stress response in children undergoing surgery for repair of congenital heart diseases utilizing cardiopulmonary bypass in the setting of fast tracking or early tracheal extubation. Furthermore, we wanted to evaluate the correlation between blunting the stress response and the perioperative clinical outcomes., Design: Prospective, randomized, double-blinded study., Setting: Single center from December 2008 to May of 2011., Patients: Forty-eight subjects (low-dose fentanyl plus placebo, n = 16; high-dose fentanyl plus placebo, n = 17; low-dose fentanyl plus dexmedetomidine, n = 15) were studied between ages 30 days to 3 years old who were scheduled to undergo repair for a ventricular septal defect, atrioventricular septal defect, or Tetralogy of Fallot., Methods: Children undergoing surgical repair of congenital heart disease were randomized to receive low-dose fentanyl (10 mcg/kg; low-dose fentanyl), high-dose fentanyl (25mcg/kg; high-dose fentanyl), or low-dose fentanyl plus dexmedetomidine (as a 1 mcg/kg loading dose followed by infusion at 0.5mcg/kg/hr until separation from cardiopulmonary bypass. In addition, patients received a volatile anesthetic agent as needed to maintain hemodynamic stability. Blood samples were tested for metabolic, hormonal and cytokine markers at baseline, after sternotomy, after the start of cardiopulmonary bypass, at the end of the procedure and at 24 hours postoperatively., Measurements and Main Results: Forty-eight subjects (low-dose fentanyl plus placebo, n = 16; high-dose fentanyl plus placebo, n = 17; low-dose fentanyl plus dexmedetomidine, n = 15) were studied. Subjects in the low-dose fentanyl plus placebo group had significantly higher levels of adrenocorticotropic hormone, cortisol, glucose, lactate, and epinephrine during the study period. The lowest levels of stress markers were seen in the high-dose fentanyl plus placebo group both over time (adrenocorticotropic hormone, p= 0.01; glucose, p = 0.007) and at individual time points (cortisol and lactate at the end of surgery, epinephrine poststernotomy; p < 0.05). Subjects in the low-dose fentanyl plus dexmedetomidine group had lower lactate levels at the end of surgery compared with the low-dose fentanyl plus placebo group (p < 0.05). Although there were no statistically significant differences in plasma cytokine levels between the three groups, the low-dose fentanyl plus placebo group had significantly higher interleukin-6:interleukin-10 ratio at 24 hours postoperatively (p < 0.0001). In addition, when compared with the low-dose fentanyl plus placebo group, the low-dose fentanyl plus dexmedetomidine group showed a lower norepinephrine level from baseline at poststernotomy, after the start of cardiopulmonary bypass, and at the end of surgery (p ≤ 0.05). Subjects in the low-dose fentanyl plus placebo group had more postoperative narcotic requirement (p = 0.004), higher prothrombin time (p ≤ 0.03), and more postoperative chest tube output (p < 0.05). Success of fast tracking was not significantly different between groups (low-dose fentanyl plus placebo 75%, high-dose fentanyl plus placebo 82%, low-dose fentanyl plus dexmedetomidine 93%; p = 0.39)., Conclusions: The use of low-dose fentanyl was associated with the greatest stress response, most coagulopathy, and highest transfusion requirement among our cohorts. Higher dose fentanyl demonstrated more favorable blunting of the stress response. When compared with low-dose fentanyl alone, the addition of dexmedetomidine improved the blunting of the stress response, while achieving better postoperative pain control.
- Published
- 2013
- Full Text
- View/download PDF
37. Aggressive coronary artery vasculopathy after combined heart-lung transplantation.
- Author
-
Hayes D Jr, Baker PB, Astor TL, Preston TJ, Kirkby S, Galantowicz M, and Hoffman TM
- Subjects
- Adult, Biopsy, Bronchiolitis Obliterans etiology, Cardiovascular Agents therapeutic use, Coronary Angiography, Coronary Artery Disease diagnosis, Coronary Artery Disease drug therapy, Fatal Outcome, Female, Graft Rejection drug therapy, Graft Rejection etiology, Humans, Immunosuppressive Agents therapeutic use, Treatment Outcome, Young Adult, Coronary Artery Disease etiology, Heart Defects, Congenital surgery, Heart-Lung Transplantation adverse effects
- Abstract
Combined heart-lung transplantation remains as a treatment option for patients with cardiopulmonary failure. There is speculation that lung grafts protect the heart from developing graft vasculopathy after combined heart-lung transplantation. This protective mechanism is more likely, at best, a delay in the onset of coronary artery vasculopathy. We present our experiences in two cases of an aggressive form of cardiac allograft vasculopathy after combined heart-lung transplantation that resulted in the death of both patients., (© 2012 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
38. Combined heart-lung transplantation: a perspective on the past and the future.
- Author
-
Hayes D Jr, Galantowicz M, and Hoffman TM
- Subjects
- Familial Primary Pulmonary Hypertension, Humans, Treatment Outcome, Eisenmenger Complex surgery, Forecasting, Heart Defects, Congenital surgery, Heart-Lung Transplantation trends, Hypertension, Pulmonary surgery
- Abstract
During the last 20 years, there has been a shift away from combined heart-lung transplantation (HLT) in favor of bilateral lung transplantation. This paradigm shift allowed for the donor heart to be transplanted to another patient. However, HLT remains to be the definitive surgical treatment for certain congenital heart disorders and Eisenmenger's syndrome. With a growing population of adult patients with congenital heart disease, there remains a need for HLT. This article provides a perspective on the past and the future of HLT.
- Published
- 2013
- Full Text
- View/download PDF
39. Cardiac management in neuromuscular diseases.
- Author
-
Allen HD, Thrush PT, Hoffman TM, Flanigan KM, and Mendell JR
- Subjects
- Cardiomyopathies etiology, Cardiomyopathies physiopathology, Humans, Muscular Dystrophies, Limb-Girdle complications, Muscular Dystrophy, Duchenne complications, Muscular Dystrophy, Emery-Dreifuss complications, Myotonic Dystrophy complications, Cardiomyopathies diagnosis, Cardiomyopathies therapy, Neuromuscular Diseases complications, Neuromuscular Diseases physiopathology
- Abstract
This article addresses the pathophysiology, diagnostic approaches, and therapeutic options in the more common forms of muscular dystrophy, especially those seen in pediatric and young adult populations. The major emphasis is on the dystrophinopathies because their treatment options are templates for those used in various other forms of dystrophy. Most patients with cardiomyopathy are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, with other agents added as the disease progresses. Destination therapies and transplantation options are mentioned where appropriate. Some dystrophies can have significant conduction abnormalities requiring pacemaker treatment. Others with ventricular tachydysrhythmias may necessitate internal cardiac defibrillator placement., (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
40. Has late rejection decreased in pediatric heart transplantation in the current era? A multi-institutional study.
- Author
-
Ameduri RK, Zheng J, Schechtman KB, Hoffman TM, Gajarski RJ, Chinnock R, Naftel DC, Kirklin JK, Dipchand AI, and Canter CE
- Subjects
- Child, Child, Preschool, Female, Humans, Infant, Male, Prospective Studies, Risk Factors, Time Factors, Graft Rejection epidemiology, Heart Transplantation
- Abstract
Background: Late (occurring >1 year) rejection (LR) has been shown to increase mortality and morbidity after pediatric heart transplantation (HTx). The incidence of rejection has decreased in the first year after pediatric HTx in the current era. We hypothesized a similar phenomenon has occurred with LR., Methods: The Pediatric Heart Transplant Study database was used to analyze the effects of era (1993 to 1998 vs 1999 to 2007) and other factors on the prevalence of LR and its relationship to mortality, moderate-severe coronary vasculopathy (CAV) and retransplantation., Results: Freedom from first LR (59% vs 69% 5-year post-HTx, p < 0.001) and recurrent LR (p < 0.001) was significantly lower in the current vs earlier era. LR was significantly (p < 0.001) associated with early rejection (ER; rejection <1 year post-HTx) in both eras. Independent risk factors for LR were: earlier era (hazard ratio [HR] 1.47, 95% confidence interval [CI] 1.25 to 1.73, p < 0.001); non-white race (HR 1.41; 95% CI 1.19 to 1.67, p < 0.001); older recipient age (HR 1.05, 95% CI 1.03 to 1.06, p < 0.001); recipient Status 2 at transplant (HR 1.21, 95% CI 1.01 to 1.45, p = 0.037); and male donor (HR 1.17; 95% CI 1.0 to 1.37, p = 0.055). Late rejectors had a similar higher risk of mortality (odds ratio [OR] 4.20, 95% CI 3.04 to 5.81, p < 0.001) and incidence of moderate-severe CAV or retransplantation (OR 2.63, 95% CI 1.78 to 3.90, p < 0.001) in both eras., Conclusions: LR has decreased in the recent era in pediatric HTx recipients. Its effect on mortality and the development of CAV has not changed over time, suggesting an ongoing need for improved primary prevention strategies., (Copyright © 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
41. Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience.
- Author
-
Daly KP, Marshall AC, Vincent JA, Zuckerman WA, Hoffman TM, Canter CE, Blume ED, and Bergersen L
- Subjects
- Adolescent, Biopsy adverse effects, Cardiac Catheterization adverse effects, Child, Child, Preschool, Female, Graft Rejection diagnostic imaging, Graft Rejection pathology, Humans, Male, Patient Safety, Retrospective Studies, Risk Factors, Coronary Angiography adverse effects, Graft Rejection diagnosis, Heart Transplantation, Myocardium pathology, Transplantation
- Abstract
Background: No prior reports documenting the safety and diagnostic yield of cardiac catheterization and endomyocardial biopsy (EMB) in heart transplant recipients include multicenter data., Methods: Data on the safety and diagnostic yield of EMB procedures performed in heart transplant recipients were recorded in the Congenital Cardiac Catheterization Outcomes Project database at 8 pediatric centers during a 3-year period. Adverse events (AEs) were classified according to a 5-level severity scale. Generalized estimating equation models identified risk factors for high-severity AEs (HSAEs; Levels 3-5) and non-diagnostic biopsy samples., Results: A total of 2,665 EMB cases were performed in 744 pediatric heart transplant recipients (median age, 12 years [interquartile range, 4.8, 16.7]; 54% male). AEs occurred in 88 cases (3.3%), of which 28 (1.1%) were HSAEs. AEs attributable to EMB included tricuspid valve injury, transient complete heart block, and right bundle branch block. Amongst 822 cases involving coronary angiography, 10 (1.2%) resulted in a coronary-related AE. There were no myocardial perforations or deaths. Multivariable risk factors for HSAEs included fewer prior catheterizations (p = 0.006) and longer case length (p < 0.001). EMB yielded sufficient tissue for diagnosis in 99% of cases. Longer time since heart transplant was the most significant predictor of a non-diagnostic biopsy sample (p < 0.001)., Conclusions: In the current era, cardiac catheterizations involving EMB can be performed in pediatric heart transplant recipients with a low AE rate and high diagnostic yield. Risk of HSAEs is increased in early post-transplant biopsies and with longer case length. Longer time since heart transplant is associated with non-diagnostic EMB samples., (Copyright © 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
42. Risk factors for late renal dysfunction after pediatric heart transplantation: a multi-institutional study.
- Author
-
Feingold B, Zheng J, Law YM, Morrow WR, Hoffman TM, Schechtman KB, Dipchand AI, and Canter CE
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Glomerular Filtration Rate, Heart Failure surgery, Heart Failure therapy, Hemodynamics, Humans, Infant, Infant, Newborn, Male, Multivariate Analysis, Proportional Hazards Models, Regression Analysis, Risk, Risk Factors, Heart Transplantation methods, Kidney physiopathology, Kidney Diseases etiology, Pediatrics methods
- Abstract
Renal dysfunction is a major determinant of outcome after HTx. Using a large, multi-institutional database, we sought to identify factors associated with late renal dysfunction after pediatric HTx. All patients in the PHTS database with eGFR ≥60 mL/min/1.73 m(2) at one yr post-HTx (n = 812) were analyzed by Cox regression for association with risk factors for eGFR <60 mL/min/1.73 m(2) at >1 yr after HTx. Freedom from late renal dysfunction was 71% and 57% at five and 10 yr. Multivariate risk factors for late renal dysfunction were earlier era of HTx (HR 1.84; p < 0.001), black race (HR 1.42; p = 0.048), rejection with hemodynamic compromise in the first year after HTx (HR 1.74; p = 0.038), and lowest quartile eGFR at one yr post-HTx (HR 1.83; p < 0.001). Renal function at HTx was not associated with onset of late renal dysfunction. Eleven patients (1.4%) required chronic dialysis and/or renal transplant during median follow-up of 4.1 yr (1.5-12.6). Late renal dysfunction is common after pediatric HTx, with blacks at increased risk. Decreased eGFR at one yr post-HTx, but not at HTx, predicts onset of late renal dysfunction. Future research on strategies to minimize late renal dysfunction after pediatric HTx may be of greatest benefit if focused on these subgroups., (© 2011 John Wiley & Sons A/S.)
- Published
- 2011
- Full Text
- View/download PDF
43. Pediatric sub-specialist controversies in the treatment of congenital heart disease in trisomy 13 or 18.
- Author
-
Yates AR, Hoffman TM, Shepherd E, Boettner B, and McBride KL
- Subjects
- Cohort Studies, Female, Heart Defects, Congenital genetics, Humans, Male, Workforce, Chromosomes, Human, Pair 13, Chromosomes, Human, Pair 18, Heart Defects, Congenital therapy, Pediatrics, Physicians psychology, Trisomy
- Abstract
Trisomy 13 and 18 are associated with congenital heart disease. Cardiac palliation has been reported in the literature, but is not usually done in this population. Thus, a multi-disciplinary team may experience controversy in formulating a care plan that includes cardiac intervention. Our objective was to determine differences in recommendations for cardiac intervention in this population between physicians specializing in pediatric cardiac critical care, neonatology, and genetics. A web-based survey was performed between April 2007 and August 2008. This survey evaluated surgical and transcatheter cardiac palliations that had been performed for individuals with trisomy 13 or 18 at the respondent's institution, the respondent's recommendations for cardiac intervention in hypothetical symptomatic patients with trisomy 13 or trisomy 18 and the influence of parental preference on these recommendations. Eight hundred fifty-nine responses were obtained from a primarily academic practice setting (59%). Cardiologists were most likely to recommend intervention; low risk interventions were recommended by 32% of cardiologists, 7% of neonatologists and 20% of geneticists. Parental request to intervene resulted in a 3 fold increased in the likelihood of all specialist recommending intervention. Counseling of families frequently occurred by multiple sub specialists (50%) and there was frequently (71%) a difference in opinion. Individuals with trisomy 13 or 18 are receiving cardiac intervention at many institutions. Cardiologists were more likely than geneticists or neonatologists to recommend intervention on all heart lesions other than single ventricle palliation which no specialists recommended. Parental wishes that "everything be done" significantly influenced all specialists' recommendations.
- Published
- 2011
- Full Text
- View/download PDF
44. Invited commentary.
- Author
-
Hoffman TM
- Subjects
- Female, Humans, Male, Fontan Procedure statistics & numerical data, Heart Defects, Congenital mortality, Risk Assessment methods
- Published
- 2011
- Full Text
- View/download PDF
45. Newer inotropes in pediatric heart failure.
- Author
-
Hoffman TM
- Subjects
- Child, Clinical Trials as Topic, Drug Administration Schedule, Etiocholanolone analogs & derivatives, Etiocholanolone pharmacokinetics, Etiocholanolone therapeutic use, Heart Failure physiopathology, Humans, Hydrazones adverse effects, Hydrazones pharmacokinetics, Hydrazones therapeutic use, Milrinone adverse effects, Milrinone pharmacokinetics, Milrinone therapeutic use, Pyridazines adverse effects, Pyridazines pharmacokinetics, Pyridazines therapeutic use, Simendan, Treatment Outcome, Cardiotonic Agents adverse effects, Cardiotonic Agents pharmacokinetics, Cardiotonic Agents therapeutic use, Heart Failure drug therapy, Myocardial Contraction drug effects
- Abstract
In the cardiac setting in pediatrics, inotropic support is often employed based on the extrapolation from adult studies, the underlying pathophysiology, pharmacodynamics of inotropes, and anecdotal experience. Large pediatric critical care studies involving inotropic support are rare. Levosimendan, a calcium-sensitizing agent with inotropic and lusitropic properties, is a pyridazole dinitrate derivative with linear pharmacokinetics and a relatively short half life, although an active metabolite, namely, OR-1876, has a half life of 70-80 hours accounting for a prolonged effect. Albeit few, pediatric studies involving levosimendan suggest similar pharmacokinetics to adults with heart failure, an efficacy at least equal to that of milrinone, favorable myocardial oxygen effects, and an ability to decrease concomitant catecholamine dosing. Levosimendan may be a promising new agent in pediatrics, but further experience and study are warranted. Finally, istaroxime, a calcium cycling agent that is in the beginning of adult study, may be another inotrope with lusitropic properties that might be applicable to pediatric patients.
- Published
- 2011
- Full Text
- View/download PDF
46. Initial counseling prior to palliation for hypoplastic left heart syndrome.
- Author
-
Yates AR, Hoffman TM, Boettner B, Feltes TF, and Cua CL
- Subjects
- Female, Health Care Surveys, Healthcare Disparities, Humans, Hypoplastic Left Heart Syndrome complications, Hypoplastic Left Heart Syndrome mortality, Internet, Male, Patient Selection, Practice Patterns, Physicians', Preoperative Care, Residence Characteristics, Risk Assessment, Risk Factors, United States, Cardiac Surgical Procedures adverse effects, Cardiac Surgical Procedures mortality, Counseling, Hospice Care, Hypoplastic Left Heart Syndrome surgery, Palliative Care
- Abstract
Objective: Multiple surgical approaches to the initial palliation of patients with hypoplastic left heart syndrome (HLHS) have been advocated throughout the years. We sought to examine what procedure, if any, is recommended for HLHS management in regard to physician preference, anatomical variations, and concomitant medical issues., Patients and Methods: A Web-based survey of pediatric cardiologist subscribed to PediHeart was conducted., Outcome Measures: The types of palliation recommended (Norwood palliation, Sano modification, hybrid palliation, primary cardiac transplantation, or hospice care) for patients with HLHS with anatomic or comorbid variants were queried. Counseling provided by the physicians to families was also documented as regards survival and outcomes., Results: Two hundred physicians (21% female) who averaged 12.3 years removed from training responded to the survey. US East Coast and Midwest respondents were more likely to recommend Norwood palliation (54% and 60%, respectively) and the US South and West respondents preferred Sano modification (73% and 82%, respectively). Norwood or Sano palliation was recommended over hospice care, hybrid palliation, or cardiac transplant for patients with an intact atrial septum (P < 0.05), moderate to severe tricuspid regurgitation (P < 0.05), or low birth weight defined as less than 2 kg (P < 0.05). Hospice was preferred in low-birth-weight infants over hybrid palliation or cardiac transplantation (P < 0.05). Hospice was recommended over any other palliation for premature infants (less than 30 weeks gestation), chromosomal abnormalities, or end-organ dysfunction (P < 0.05)., Conclusions: This survey demonstrates that different palliative options are primarily recommended by caretakers based upon institutional location and patient characteristics. Prospective comparative trials may force a rethinking of this approach over time., (© 2011 Copyright the Authors. Congenital Heart Disease © 2011 Wiley Periodicals, Inc.)
- Published
- 2011
- Full Text
- View/download PDF
47. Reversion-reporter transgenes to analyze all six base-substitution pathways in Arabidopsis.
- Author
-
Bollmann SR, Tominey CM, Hoffman PD, Hoffman TM, and Hays JB
- Subjects
- Alleles, Arabidopsis enzymology, Arabidopsis growth & development, Arabidopsis radiation effects, Base Sequence, Gene Dosage genetics, Glucuronidase genetics, Glucuronidase metabolism, Immunohistochemistry, Ions, Metals, Molecular Sequence Data, Mutagenesis genetics, Mutagenesis radiation effects, Mutant Proteins genetics, Mutant Proteins metabolism, Mutation genetics, Plants, Genetically Modified, Sequence Analysis, DNA, Ultraviolet Rays, Amino Acid Substitution genetics, Arabidopsis genetics, Genes, Reporter genetics, Genetic Engineering methods, Transgenes genetics
- Abstract
To expand the repertoire of Arabidopsis (Arabidopsis thaliana) mutation-reporter transgenes, we constructed six mutant alleles in the same codon of the β-glucuronidase-encoding GUS transgene. Each allele reverts to GUS+ only via a particular one of the six transition/transversion pathways. AcV5 epitope tags, fused carboxyl terminal to the inactive GUS- proteins, enabled semiquantitative immunoassays in plant protein extracts. Spontaneous G:C→T:A transversions, previously not measured using reporter transgenes, were quite frequent. This may reflect mispairing of adenine with 8-oxoguanine in DNA attacked by endogenous oxyradicals. Spontaneous G:C→A:T was modest and other reversions were relatively low, as reported previously. Frequencies of ultraviolet C-induced TT→TC and TC→TT reversions were both high. With increased transgene copy number, spontaneous G:C→T:A reversions increased but ultraviolet C-induced reversions decreased. Frequencies of some reversion events were reduced among T4 versus T3 generation plants. Based on these and other analyses of sources of experimental variation, we propose guidelines for the employment of these lines to study genotoxic stress in planta.
- Published
- 2011
- Full Text
- View/download PDF
48. Invited commentary.
- Author
-
Hoffman TM
- Subjects
- Heart Septal Defects, Atrial mortality, Heart Septal Defects, Ventricular mortality, Humans, Heart Septal Defects, Atrial surgery, Heart Septal Defects, Ventricular surgery
- Published
- 2010
- Full Text
- View/download PDF
49. Heart failure treatment in the intensive care unit in children.
- Author
-
Jefferies JL, Hoffman TM, and Nelson DP
- Subjects
- Algorithms, Anemia physiopathology, Arrhythmias, Cardiac diagnosis, Arrhythmias, Cardiac physiopathology, Cardiac Output, Low, Cardiotonic Agents therapeutic use, Catecholamines blood, Child, Diuretics therapeutic use, Electrocardiography, Heart Defects, Congenital physiopathology, Heart Defects, Congenital surgery, Heart Failure diagnosis, Heart Failure etiology, Heart Failure physiopathology, Heart-Assist Devices, Humans, Inflammation physiopathology, Intensive Care Units, Liver Diseases physiopathology, Myocardial Contraction physiology, Myocardium pathology, Natriuretic Peptides blood, Nervous System Diseases physiopathology, Oxygen Consumption physiology, Postoperative Care, Renal Insufficiency physiopathology, Renin-Angiotensin System physiology, Respiration, Artificial methods, Vasodilator Agents therapeutic use, Critical Care, Heart Failure therapy
- Abstract
Although pediatric heart failure is generally a chronic, progressive disorder, recovery of ventricular function may occur with some forms of cardiomyopathy. Guidelines for the management of chronic heart failure in adults and children have recently been published by the International Society for Heart and Lung Transplantation the American College of Cardiology, and the American Heart Association. The primary aim of heart failure therapy is to reduce symptoms, preserve long-term ventricular performance, and prolong survival primarily through antagonism of the neurohormonal compensatory mechanisms. Because some medications may be detrimental during an acute decompensation, physicians who manage these patients as inpatients must be knowledgeable about the medications and therapeutic goals of chronic heart failure treatment. Understanding the mechanisms of chronic heart failure may foster improved understanding of the treatment of decompensated heart failure., (Copyright © 2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
50. Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing.
- Author
-
Fitzgerald-Butt SM, Byrne L, Gerhardt CA, Vannatta K, Hoffman TM, and McBride KL
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Female, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, United States, Cardiomyopathy, Hypertrophic, Familial prevention & control, Caregivers, Genetic Counseling, Genetic Testing, Health Knowledge, Attitudes, Practice
- Abstract
Hypertrophic cardiomyopathy (HCM) is a common autosomal dominant condition with an increased risk of sudden cardiac death. Although clinical genetic testing can be used for confirmation of a clinical diagnosis as well as a predictive test, based on our clinical experience it is underutilized. Therefore, we developed and administered a questionnaire to assess potential determinants of parental interest in this testing. Of the 30 adult caregivers who participated, 80% had heard of genetic testing, whereas only 30% knew about genetic testing specifically for HCM. Once informed of the availability, 62% said they would consider testing in the future and 28% would consider it in the next year. Participants' younger age, higher education level, knowledge of carrier testing, and positive view of genetic testing were significantly associated with the participant considering HCM genetic testing for their child (p
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.